Suppr超能文献

老年人使用抗抑郁药的安全性。

Safety of antidepressants in the elderly.

作者信息

Sommer Barbara R, Fenn Howard, Pompei Peter, DeBattista Charles, Lembke Anna, Wang Po, Flores Ben

机构信息

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305-5723, USA.

出版信息

Expert Opin Drug Saf. 2003 Jul;2(4):367-83. doi: 10.1517/14740338.2.4.367.

Abstract

Until the 1980s, the two major classes of antidepressants, the tricyclics and the monoamine oxidase inhibitors (MAOIs), were effective but had severe side effects, requiring monitoring by psychiatrists. The past several years have brought new classes of antidepressants that are safer for the patient to take and far easier for the non-psychiatrist to prescribe. Whilst this is of enormous value, it leaves the physician with the dilemma of which one to prescribe. These new antidepressants cannot safely be used interchangeably. This paper will discuss each of the antidepressants presently available, with particular emphasis on safety in the elderly. Drug interactions, side effects and particular challenges to the older patient will be described. The authors will then advise a general strategy for prescribing antidepressants.

摘要

直到20世纪80年代,两类主要的抗抑郁药,即三环类药物和单胺氧化酶抑制剂(MAOIs),虽然有效,但具有严重的副作用,需要精神科医生进行监测。在过去几年中,出现了新型抗抑郁药,对患者来说服用更安全,非精神科医生开处方也更容易。虽然这具有巨大价值,但却让医生面临开哪种药的两难困境。这些新型抗抑郁药不能安全地交替使用。本文将讨论目前可用的每种抗抑郁药,特别强调老年人用药的安全性。将描述药物相互作用、副作用以及老年患者面临的特殊挑战。作者随后将给出抗抑郁药处方的一般策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验